Page 36 - AN-4-2

Advanced Neurology SARS-CoV-2 mechanisms of neurological impact

manifestations of post-acute sequelae of SARS-CoV-2 and risk factors for delayed return to usual health among
infection. Curr Neurol Neurosci Rep. 2021;21(9):44. outpatients with COVID-19 in a multistate health care
doi: 10.1007/s11910-021-01130-1 systems network - United States, March-June 2020. MMWR
Morb Mortal Wkly Rep. 2020;69(30):993‑998.
28. Amenta EM, Spallone A, Rodriguez-Barradas MC, El
Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: doi: 10.15585/mmwr.mm6930e1
An overview and approach to classification. Open Forum 39. Graham EL, Clark JR, Orban ZS, et al. Persistent neurologic
Infect Dis. 2020;7(12):ofaa509. symptoms and cognitive dysfunction in non-hospitalized
doi: 10.1093/ofid/ofaa509 Covid-19 “long haulers”. Ann Clin Transl Neurol.
2021;8(5):1073‑1085.
29. Goertz YMJ, Van Herck M, Delbressine JM, et al. Persistent
symptoms 3 months after a SARS-CoV-2 infection: The doi: 10.1002/acn3.51350
post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542‑ 40. Shanley JE, Valenciano AF, Timmons G, et al. Longitudinal
2020. evaluation of neurologic-post acute sequelae SARS-
doi: 10.1183/23120541.00542-2020 CoV-2 infection symptoms. Ann Clin Transl Neurol.
2022;9(7):995‑1010.
30. Sykes DL, Holdsworth L, Jawad N, Gunasekera P,
Morice AH, Crooks MG. Post-COVID-19 symptom burden: doi: 10.1002/acn3.51578
What is Long‑COVID and how should we manage it? Lung. 41. Davis HE, Assaf GS, McCorkell L, et al. Characterizing long
2021;199(2):113‑119. COVID in an international cohort: 7 months of symptoms
doi: 10.1007/s00408-021-00423-z and their impact. EClinicalMedicine. 2021;38:101019.
31. Orru G, Bertelloni D, Diolaiuti F, et al. Long-COVID doi: 10.1016/j.eclinm.2021.101019
syndrome? A study on the persistence of neurological, 42. Rank A, Tzortzini A, Kling E, et al. One year after mild
psychological and physiological symptoms. Healthcare COVID‑19: The majority of patients maintain specific
(Basel). 2021;9(5):575. immunity, but one in four still suffer from long-term
doi: 10.3390/healthcare9050575 symptoms. J Clin Med. 2021;10(15):3305.
32. Abboud H, Abboud FZ, Kharbouch H, Arkha Y, El doi: 10.3390/jcm10153305
Abbadi N, El Ouahabi A. COVID-19 and SARS-Cov-2 43. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute
infection: Pathophysiology and clinical effects on the COVID-19 syndrome. Nat Med. 2021;27(4):601‑615.
nervous system. World Neurosurg. 2020;140:49‑53.
doi: 10.1038/s41591-021-01283-z
doi: 10.1016/j.wneu.2020.05.193
44. Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG.
33. Berger JR. COVID-19 and the nervous system. J Neurovirol. Persistent symptoms in patients after acute COVID-19.
2020;26(2):143‑148. JAMA. 2020;324(6):603‑605.
doi: 10.1007/s13365-020-00840-5 doi: 10.1001/jama.2020.12603
34. Wang F, Kream RM, Stefano GB. Long‑term respiratory 45. Ludvigsson JF. Case report and systematic review suggest that
and neurological sequelae of COVID-19. Med Sci Monit. children may experience similar long-term effects to adults
2020;26:e928996. after clinical COVID-19. Acta Paediatr. 2021;110(3):914‑921.
doi: 10.12659/MSM.928996 doi: 10.1111/apa.15673
35. Berlit P, Bosel J, Gahn G, et al. “Neurological manifestations 46. Townsend L, Dyer AH, Jones K, et al. Persistent fatigue
of COVID-19” - guideline of the German society of following SARS-CoV-2 infection is common and
neurology. Neurol Res Pract. 2020;2:51.
independent of severity of initial infection. PLoS One.
doi: 10.1186/s42466-020-00097-7 2020;15(11):e0240784.
36. Timmons GM, Rempe T, Bevins EA, et al. CNS lymphocytic doi: 10.1371/journal.pone.0240784
vasculitis in a young woman with COVID-19 infection. 47. Belvis R. Headaches during COVID-19: My clinical case and
Neurol Neuroimmunol Neuroinflamm. 2021;8(5):e1048.
review of the literature. Headache. 2020;60(7):1422‑1426.
doi: 10.1212/NXI.0000000000001048
doi: 10.1111/head.13841
37. Sudre CH, Murray B, Varsavsky T, et al. Attributes and 48. Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge
predictors of long COVID. Nat Med. 2021;27(4):626‑631. persistent symptoms and health-related quality of life after
doi: 10.1038/s41591-021-01292-y hospitalization for COVID-19. J Infect. 2020;81(6):e4‑e6.
38. Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration doi: 10.1016/j.jinf.2020.08.029

Volume 4 Issue 2 (2025) 30 doi: 10.36922/an.4909